Evidence map›Paper›PMID 21880634›Full record

Trial reportHaematologica2011

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Thomas Kühne, Willi Berchtold, Lisa A Michaels, Runhui Wu, Hugo Donato, Bibiana Espina, Hannah Tamary, Francesco Rodeghiero, Meera Chitlur, Johannes Rischewski and 2 more

Open access · goldAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in Haematologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prognostic Re-evaluation of Antinuclear Antibodies in Childhood Immune Thrombocytopenia.TH open : companion journal to thrombosis and haemostasis · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Thomas KühneDepartment of Oncology, Hematology University Children's Hospital Basel, Basel, Switzerland. Thomas.Kuehne@ukbb.ch
Willi Berchtold
Lisa A Michaels
Runhui Wu
Hugo Donato
Bibiana Espina
Hannah Tamary
Francesco Rodeghiero
Meera Chitlur
Johannes Rischewski
Paul Imbach
Intercontinental Cooperative ITP Study Group
Beijing Children’s Hospital · CNChildren's Hospital · TNJohnson University · USOspedale San Bortolo · ITSchneider Children's Medical Center · ILUniversity Children’s Hospital Basel · CHUniversity of Basel · CHUniversity of Teacher Education Lucerne · CHWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary immune thrombocytopenia is a bleeding diathesis with an unknown etiology in predisposed individuals with immune disturbances. Although it is claimed that children and adults differ in clinical and laboratory aspects, few data exist to corroborate this observation. Our objective was to assess comparative data from children and adults with newly diagnosed immune thrombocytopenia. DESIGN AND

methodsClinical and laboratory data of 1,784 children and 340 adults were extracted from the Pediatric and Adult Registry on Chronic Immune Thrombocytopenia. The registry represents a prospective cohort of children and adults with newly diagnosed immune thrombocytopenia. Participating investigators registered their patients immediately after the diagnosis using a web based data transfer. Children aged under 16 years were compared with adults aged 16 years and over with descriptive statistical analyses.

resultsThe presenting mean platelet count of children and adults was 18.1 and 25.4 × 10(9)/L. Signs of bleeding were reported in 24% of children and in 23% of adults, and intracranial hemorrhage in 10 of 1,784 children and in 6 of 340 adults. Co-morbidity was observed in 3.9% of children and in 30% of adults. Bone marrow aspiration and laboratory tests (antinuclear antibodies, human immunodeficiency and hepatitis C virus) were performed more frequently in adults. Children and adults were followed with a 'watch and wait' strategy in 20% and in 29%, respectively. Immunoglobulins were used more frequently in children and corticosteroids in adults.

conclusionsComparative data of children and adults with newly diagnosed immune thrombocytopenia revealed similarities in presenting platelet counts and in bleeding, whereas differences occurred in co-morbidity, diagnostic procedures and therapy.

Indexed as

Purpura, Thrombocytopenic, IdiopathicRegistriesAdolescentAdrenal Cortex HormonesAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolFemaleHumansImmunoglobulinsInfantMaleMiddle AgedAdrenal Cortex HormonesImmunoglobulins

Identifiers

PMID21880634
PMCPMC3232266
OpenAlexW2130017206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.